| 000 | 01862 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516235200.0 | ||
| 264 | 0 | _c20150811 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1538-8514 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-13-1091 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBola, Becky M | |
| 245 | 0 | 0 |
_aInhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cDec 2014 |
||
| 300 |
_a2805-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycolysis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactates _xmetabolism |
| 650 | 0 | 4 | _aMetabolomics |
| 650 | 0 | 4 |
_aMonocarboxylic Acid Transporters _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPyrimidinones _xadministration & dosage |
| 650 | 0 | 4 |
_aRadiation Tolerance _xdrug effects |
| 650 | 0 | 4 |
_aSymporters _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aChadwick, Amy L | |
| 700 | 1 | _aMichopoulos, Filippos | |
| 700 | 1 | _aBlount, Kathryn G | |
| 700 | 1 | _aTelfer, Brian A | |
| 700 | 1 | _aWilliams, Kaye J | |
| 700 | 1 | _aSmith, Paul D | |
| 700 | 1 | _aCritchlow, Susan E | |
| 700 | 1 | _aStratford, Ian J | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 13 _gno. 12 _gp. 2805-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-13-1091 _zAvailable from publisher's website |
| 999 |
_c24247255 _d24247255 |
||